Schedule 13G ownership disclosure

Vallon Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 92023M101

Event date: 2022-05-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-22-000949
Form type
SC 13G
Filer
Lind Global Fund II LP
CIK
CIK 1871665
Filed
May 23, 2022
Reporting period
May 17, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub